L01FF02 - pembrolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
J01DI54 - ceftolozane and beta-lactamase inhibitor : Belongs to the class of other cephalosporins and penems. Used in the systemic treatment of infections.
L01FF02 - pembrolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
L01FF02 - pembrolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
J01DI54 - ceftolozane and beta-lactamase inhibitor : Belongs to the class of other cephalosporins and penems. Used in the systemic treatment of infections.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.